By Chelsea Naso ( January 11, 2016, 6:13 PM EST) -- The deal-hungry pharmaceutical space came out swinging in the New Year as Irish drugmaker Shire's $32 billion play for rare disease biotech Baxalta became 2016's first megadeal, signaling another busy year for pharma tie-ups after a record wave of mergers and acquisitions in 2015....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.